INVACARE CORPORATION (NYSE:IVC) Files An 8-K Regulation FD Disclosure

INVACARE CORPORATION (NYSE:IVC) Files An 8-K Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.

Story continues below

On January 11, 2018, Invacare Corporation (the “Company”) announced the possible relocation of the production of Küschall® manual wheelchairs from its facility in Witterswil, Switzerland to its wheelchair manufacturing facility in Fondettes, France, which the Company anticipates may be completed by mid-year 2018, subject to the outcome of the employee consultation procedure. If completed, the Company expects that this move would allow it to better optimize its wheelchair manufacturing facility in Fondettes, France. As part of this proposal, Küschall AG, a wholly owned subsidiary of the Company, has initiated the consultation procedure with the potentially affected employees, as required by Swiss law. The consultation period for these discussions is expected to last through approximately January 30, 2018.

This Current Report on Form 8-K contains forward-looking statements within the meaning of the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are those that describe future outcomes or expectations that are usually identified by words such as “will,” “should,” “could,” “plan,” “intend,” “expect,” “continue,” “forecast,” “believe,” and “anticipate” and include, for example, any statement made regarding the Company's future results. Actual results may differ materially as a result of various risks and uncertainties, including the possible relocation not being timely completed, if completed at all; if the possible relocation is completed, the impact of any undertakings required of the Company in order to obtain requisite approvals; prior to the completion of the possible relocation, the Company’s business experiencing disruptions due to relocation-related uncertainty or other factors; and those other risks and uncertainties expressed in the cautionary statements and risk factors in the Company’s annual report on Form 10-K, quarterly reports on Form 10-Q and other filings with the Securities and Exchange Commission. The Company may not be able to predict and may have little or no control over many factors or events that may influence its future results and, except as required by law, shall have no obligation to update any forward-looking statements.


Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific. The Company manufactures and distributes three product categories: mobility and seating, lifestyle and respiratory therapy. It provides medical device solutions for congenital (cerebral palsy, muscular dystrophy and spina bifida), acquired (stroke, spinal cord injury, traumatic brain injury, post-acute recovery and pressure ulcers) and degenerative (amyotrophic lateral sclerosis, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly and bariatric) ailments. The Company sells its products to home medical equipment providers with retail and e-commerce channels, residential living operators, distributors and government health services.

An ad to help with our costs